tosis (formerly von Recklinghausen's disease) is a rare genetic condition with an incidence of approximately 1 in 3000 (Table 1) . Although the presentation can vary, it often results in multiple cutaneous neurofibromas or large plexiform neurofibromas. Although several benign and malignant tumors have been associated with type I neurofibromatosis, until recently, glomus tumors have not been believed to be part of the tumor spectrum in patients with neurofibromatosis.
Despite the fact that plastic surgeons treat both glomus tumors and neurofibromatosis patients, this association has not been well described in the plastic surgery literature. The purpose of this review is to summarize the existing literature on the association between glomus tumors and type I neurofibromatosis and to characterize glomus tumors that present in patients with neurofibromatosis in terms of sex distribution, tumor location, and tumor burden.
METHODS
PubMed, Ovid (MEDLINE), and Cochrane database searches limited to English language publications using the terms "glomus tumor," "glomus tumour," "glomangioma," and "neurofibromatosis" were performed. Additional articles were also identified by a manual reference search of relevant articles generated by the database searches. Articles that were nonrelevant or duplicative were excluded, and a single article that was not accessible was also excluded.
1 Figure 1 provides details of the systematic database search. A total of 15 articles were included in the review (Table 2 ). Information about the strength and the genetics of the association was recorded. Data on patient sex, tumor location, and number of tumors were recorded.
RESULTS
A total of 36 patients with neurofibromatosis and glomus tumors were identified. Among the reports that included data on patient sex, 79% were female. Among the reports that included data on the number of tumors per patient, there was an average of 1.4 glomus tumors per patient, with 32% of patients having multifocal tumors. Among the reports that described tumor location, 62% of patients had tumors that arose in a subungual location and 38% of patients had nonsubungual tumors. Table 3 summarizes the data obtained from the case reports.
DISCUSSION
In 1938, Klaber 2 provided the first report of a glomus tumor arising in a patient with neurofibromatosis. In this report, a "blue nodule" was excised from the right calf of a 13-year-old girl with type I neurofibromatosis. She was also noted to have similar soft blue nodules on the neck and left heel that were tender to deep pressure. The literature contains no further reports of glomus tumors in patients with neurofibromatosis until 1995, when Sawada et al 3 reported 3 patients with type I neurofibromatosis and subungual glomus tumors. Between 1995 and 2013, 13 more case reports described glomus tumors arising in the setting of type I neurofibromatosis. Although many of the authors speculated about the possibility of an association, it was not confirmed until 2009.
In 2009, Brems et al 4 defined the genetics of the association between glomus tumors and type I neurofibromatosis. Type I neurofibromatosis is an autosomal dominant condition caused by loss or inactivation of 1 allele of the tumor suppressor gene NF1. The authors demonstrated that glomus tumors that arise in patients with type I neurofibromatosis are due to biallelic inactivation of the NF1 gene, or a "second hit" that occurs specifically within the α-smooth muscle actin-positive cells of the glomus body. Interestingly, even though these glomus tumors are histologically identical to isolated, sporadic glomus tumors, isolated glomus tumors do not exhibit the same NF1 mutations.
In 2013, Harrison et al 5 performed a case-control epidemiologic study in which a cohort of patients who had undergone glomus tumor excision were compared with a similar cohort of patients who had undergone excision of other benign hand lesions. Twenty-nine percent of patients who had undergone glomus tumor excision were found to carry the diagnosis of neurofibromatosis, whereas none of the patients in the control cohort had neurofibromatosis, resulting in a calculated odds ratio of 168:1. Although the number of patients in this study was low, it does support a strong epidemiologic association between neurofibromatosis and glomus tumors. It should be noted, however, that even though the association between glomus tumors and type I neurofibromatosis is strong, it would probably be more common for a plastic surgeon or hand surgeon to encounter isolated, sporadic glomus tumors in clinical practice, due to the fact that type I neurofibromatosis is rare.
Some authors have speculated that glomus tumors arising in the setting of type I neurofibromatosis are more likely to be multifocal, rather than solitary. 4 In the literature, the incidence of multifocality for sporadic glomus tumors varies widely, ranging from 2.3% to 25%. [6] [7] [8] Multifocality has been associated with children, familial inheritance, and pregnancy. [9] [10] [11] Multiple hereditary glomus tumors is a distinct, well-described entity and represents a subset of patients in whom multiple glomus tumors develop at a young age. Multiple hereditary glomus tumors are inherited in an autosomal dominant fashion through a glomulin gene mutation. 12, 13 In this review of patients with neurofibromatosis, the average number of tumors per patient was 1.4, with 32% of patients having multiple glomus tumors. Although this value is slightly greater than is typically reported for isolated sporadic glomus tumors, a statistical comparison is not possible. Regardless of whether multifocality is more common in neurofibromatosisassociated glomus tumors than in sporadic glomus tumors, it is important to note that multifocality is not uncommon.
Glomus tumors associated with type I neurofibromatosis do not appear to differ from isolated glomus tumors in terms of sex distribution. In this review, 79% of patients were female. Sporadic glomus tumors are also known to be much more common in women (although there is no sex predilection for multiple familial glomus tumors). 12 In a large study of isolated glomus tumors, which included 51 patients with glomus tumors of the hand, 86% of patients were female.
14 Type I neurofibromatosis, an autosomal dominant disease, has an equal sex distribution, suggesting that the female predominance that is seen in both sporadic and neurofibromatosis-associated glomus tumors is unrelated to the association with neurofibromatosis. Why this female predilection is not present in multiple familial glomus tumors is unknown. Fig. 1 . algorithm demonstrating the details of the database search. Glomus tumors have been found almost everywhere in the body, including the head and face, back, foot, ankle, vagina, penis, lung, various visceral organs, cervix, and bone. [15] [16] [17] [18] [19] However, for isolated sporadic glomus tumors, the subungual location is by far the most common (60%-80%). [20] [21] [22] Sex also plays a role in tumor location, with a subungual location being more common in women, but with no sex preference noted at other locations. 12 In this review, 62% of tumors were subungual, which is consistent with reports of isolated sporadic glomus tumors.
An understanding of the association between type I neurofibromatosis and glomus tumors is important for plastic surgeons and hand surgeons. Because type I neurofibromatosis is usually diagnosed at a young age 23 and glomus tumors typically occur in adults, it is unlikely that the surgeon will see a patient with a glomus tumor who has undiagnosed neurofibromatosis. However, this clinical scenario can occur, and glomus tumors in patients with type I neurofibromatosis in the pediatric population have been described. 4 Therefore, the surgeon should always keep the diagnosis of type I neurofibromatosis in mind when a glomus tumor is identified. A more likely scenario would be a patient with known neurofibromatosis presenting with an undiagnosed painful lesion in the fingertip or elsewhere. If the presentation of the glomus tumor is classic, with a single painful subungual tumor, the diagnosis and treatment may be straightforward. However, in this study, an atypical presentation was common, with 38% of patients having nonsubungual tumors and 32% of patients having multifocal tumors. Even with classically presenting glomus tumors, the diagnosis is often delayed, and patients may see multiple physicians before receiving a diagnosis and treatment.
14 Therefore, in patients with known type I neurofibromatosis, the presence of focal subcutaneous pain should lead to the consideration of the possibility of a glomus tumor. If the diagnosis is in question, magnetic resonance imaging can be diagnostic. A glomus tumor will have low signal intensity on T1-weighted images and very high signal intensity on T2-weighted images, with a "nidus" appearance. If gadolinium contrast is administered, post-gadolinium T1-weighted images will show marked enhancement.
CONCLUSIONS
Multiple case reports, a molecular genetics study, and a recent epidemiologic study all confirm that type I neurofibromatosis is associated with glomus tumors and that glomus tumors should be considered part of the tumor spectrum of type I neurofibromatosis. It is important for plastic surgeons and hand surgeons to be aware of this association. In the patient with type I neurofibromatosis who presents with a painful subcutaneous lesion, the diagnosis of glomus tumor must be considered. Like isolated glomus tumors, they are more common in women, usually solitary, and most commonly found in a subungual location. However, atypical presentations with multifocal or nonsubungual tumors are not unusual. It is hoped that as this association becomes more widely recognized, earlier referral, diagnosis, and tumor excision will provide pain relief and prevent delays in treatment. 
